Nanoparticles reduce hepatic cancer cell viability and angiogenesis, suggesting effective liver cancer therapy.
< 0.001), accompanied by 32% and 33% reductions in embryonic length and weight, respectively. These results underscore the synergistic potential of CS-Se-Cu NPs as dual cytotoxic and anti-angiogenic agents for liver cancer therapy.
No takes yet. Share an insight, caveat, or question.
Shahbur et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: